bioXXmed AG (FRA:T5O)

Germany · Delayed Price · Currency is EUR

0.9550

-0.0050 (-0.52%)

Last updated: Oct 22, 2026, 9:00 PM CEST

Market Cap	259.63K +34.5%
Revenue (ttm)	-269.00 +379.0%
Net Income	-184.39K
EPS	n/a
Shares Out	271.87K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.9550
Previous Close	0.9600
Day's Range	0.9550 - 0.9550
52-Week Range	0.0050 - 1.3600
Beta	5.12
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 22, 2026

About bioXXmed AG

bioXXmed AG, a holding company, investing in biotechnology and medical technology companies. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2000

Employees 2

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol T5O

Full Company Profile

Financial Performance

In 2025, bioXXmed AG's revenue was 16,731, an increase of 378.99% compared to the previous year's 3,493. Losses were -365,390, -63.35% less than in 2024.

Financial Statements